Irritable Bowel Syndrome Treatment Market Analysis, Growth, Share, Market Trends 2027

Market Overview:

According to our latest study on “Irritable Bowel Syndrome (IBS) Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product, and Distribution Channel,” the market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 10.1% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006814/

 

Based on product, the irritable bowel syndrome (IBS) treatment market is segmented into rifaximin, eluxadoline, lubiprostone, linaclotide, and others. The linaclotide segment held the largest share of the market in 2020. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period.  The market growth for this segment is attributed to the key factors such as the increasing manufacturing of generic version of linaclotide and rising market consolidation for developing and commercializing linaclotide to treat IBS.

Ironwood Pharmaceuticals, Inc., AbbVie., Sebela Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Alfasigma S.p.A., Astellas Pharma Inc., AstraZeneca, Synthetic Biologics, Inc., Bausch + Lomb Incorporated; and Lannett Company Inc are among the leading companies operating in the global irritable bowel syndrome (IBS) treatment market.

Buy Now: https://www.theinsightpartners.com/buy/TIPRE00006814/

The report segments global irritable bowel syndrome (IBS) treatment market as follows:

By Type

IBS with Diarrhea (IBS-D)IBS with Constipation (IBS-C)Mixed IBS (IBS-M)

By Product

RifaximinEluxadolineLinaclotideLubiprostoneOthers

By Distribution Channel

Hospitals PharmaciesDrug Stores and Retail PharmaciesOnline Pharmacies

By Geography

North AmericaUSCanadaMexicoEuropeFranceGermanyUKSpainItalyRest of EuropeAsia Pacific (APAC)ChinaIndiaJapanAustraliaSouth KoreaRest of APACMiddle East and Africa (MEA)Saudi ArabiaUAESouth AfricaRest of MEASouth and Central America (SCAM)BrazilArgentinaRest of SCAM

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: [email protected] 

Phone: +1-646-491-9876

 

0